Diane Bray, DPM
Foot Surgery · Hershey, PANPI 1225094642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $492 and has fallen 51.2% since, to $240 in 2025.
Across 57 payments — averaging $21.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$147
- Stryker$136
- GRT US Holding, Inc.$108
- Tactile Systems Technology Inc$100
- Medtronic$98
- Averitas Pharma Inc.$86
- plus $537 from 16 others
What the payments were for
- Food & beverage$1,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 4 | $147 |
| Stryker | 3 | $136 |
| GRT US Holding, Inc. | 6 | $108 |
| Tactile Systems Technology Inc | 6 | $100 |
| Medtronic | 3 | $98 |
| Averitas Pharma Inc. | 5 | $86 |
| Organogenesis Inc. | 5 | $74 |
| AbbVie | 3 | $59 |
| Kerecis Limited | 2 | $54 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Smith+Nephew | 3 | $52 |
| Convatec Inc. | 2 | $34 |
| KCI USA, Inc. | 2 | $32 |
| Nevro Corp. | 2 | $32 |
| Reapplix Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| DJO, LLC | 1 | $20 |
| Vertex | 1 | $17 |
| Solventum Corporation | 1 | $16 |
| Reddress USA, Inc. | 1 | $15 |
| Zimvie Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$1,213 in reported general payments places this provider in the 65th percentile of 67 foot surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 13 | $9,293 |
| Ammonium Lactate | 109 | $1,884 |
| Ciclopirox | 52 | $1,155 |
| Imiquimod | 42 | $1,145 |
| Ketoconazole | 27 | $222 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $110 |
| Doxycycline Hyclate | 20 | $105 |
| Mupirocin | 20 | $104 |
| Cephalexin | 20 | $67 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Hershey
- Joshua ScollBensalem$18K
- Derrico QuattroneJefferson Hills$6K
- Dawn SteinGrove City$5K
- Robert NortonPhiladelphia$4K
- Alyssa FitchLancaster$4K
- Peter LarnedKing Of Prussia$3K
- Nikki MiracleBeaver Falls$3K
- Raymond FritzAllentown$2K
- Pamela GekasBryn Mawr$2K
- David BernsteinWayne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.